share_log

InnovAge Holding Corp. (NASDAQ:INNV) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

InnovAge Holding Corp. (NASDAQ:INNV) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Innovage Holding Corp.(纳斯达克股票代码:INNV)第三季度业绩刚刚公布:以下是分析师对明年的预测
Simply Wall St ·  05/09 07:57

Investors in InnovAge Holding Corp. (NASDAQ:INNV) had a good week, as its shares rose 4.4% to close at US$4.26 following the release of its quarterly results. Revenue of US$193m came in 2.5% ahead of expectations, although statutory earnings didn't fare nearly so well, recording a loss of US$0.04, a 14% miss. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

Innovage Holding Corp.(纳斯达克股票代码:INNV)的投资者度过了愉快的一周,在公布季度业绩后,其股价上涨了4.4%,收于4.26美元。1.93亿美元的收入比预期高出2.5%,尽管法定收益表现不佳,亏损0.04美元,跌幅14%。对于投资者来说,盈利是一个重要时刻,因为他们可以追踪公司的业绩,查看分析师对明年的预测,看看对公司的情绪是否发生了变化。根据这些结果,我们收集了最新的法定预测,以了解分析师是否改变了盈利模式。

earnings-and-revenue-growth
NasdaqGS:INNV Earnings and Revenue Growth May 9th 2024
纳斯达克GS:INNV 收益和收入增长 2024 年 5 月 9 日

Following the latest results, InnovAge Holding's four analysts are now forecasting revenues of US$848.7m in 2025. This would be a meaningful 14% improvement in revenue compared to the last 12 months. InnovAge Holding is also expected to turn profitable, with statutory earnings of US$0.029 per share. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$847.0m and earnings per share (EPS) of US$0.031 in 2025. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a minor downgrade to their earnings per share forecasts.

根据最新业绩,Innovage Holding的四位分析师现在预测2025年的收入为8.487亿美元。与过去12个月相比,这将使收入大幅增长14%。预计InnovAge Holding也将实现盈利,法定每股收益为0.029美元。然而,在最新财报公布之前,分析师曾预计2025年收入为8.470亿美元,每股收益(EPS)为0.031美元。因此,在最近的业绩公布之后,整体情绪似乎略有下降——收入估计没有重大变化,但分析师确实对每股收益的预测进行了小幅下调。

It might be a surprise to learn that the consensus price target was broadly unchanged at US$6.50, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic InnovAge Holding analyst has a price target of US$7.00 per share, while the most pessimistic values it at US$6.00. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth.

得知共识目标股价基本保持不变,为6.50美元,这可能会令人惊讶,分析师明确表示,预期的收益下降预计不会对估值产生太大影响。共识目标股价只是个别分析师目标的平均值,因此——可以很方便地看到基础估计值的范围有多广。最乐观的Innovage Holding分析师将目标股价定为每股7.00美元,而最悲观的分析师则将其目标股价定为6.00美元。由于估值范围如此狭窄,分析师显然对他们认为的业务价值有相似的看法。

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The analysts are definitely expecting InnovAge Holding's growth to accelerate, with the forecast 11% annualised growth to the end of 2025 ranking favourably alongside historical growth of 7.2% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 6.7% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect InnovAge Holding to grow faster than the wider industry.

现在从大局来看,我们理解这些预测的方法之一是了解它们与过去的业绩和行业增长估计相比如何。分析师肯定预计,InnovAge Holding的增长将加速,预计到2025年底的年化增长率为11%,而过去五年的历史年增长率为7.2%。相比之下,我们的数据表明,预计类似行业的其他公司(有分析师报道)的收入将以每年6.7%的速度增长。显而易见,尽管增长前景比最近更加光明,但分析师也预计,InnovAge Holding的增长速度将超过整个行业。

The Bottom Line

底线

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for InnovAge Holding. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

最大的担忧是,分析师下调了每股收益预期,这表明InnovAge Holding可能会面临业务不利因素。令人高兴的是,收入预测没有重大变化,预计该业务的增长速度仍将快于整个行业。共识目标股价没有实际变化,这表明根据最新估计,该业务的内在价值没有发生任何重大变化。

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for InnovAge Holding going out to 2026, and you can see them free on our platform here.

根据这种思路,我们认为该业务的长期前景比明年的收益重要得多。我们对Innovage Holding的预测将持续到2026年,你可以在我们的平台上免费查看。

You can also see our analysis of InnovAge Holding's Board and CEO remuneration and experience, and whether company insiders have been buying stock.

您还可以看到我们对InnovAge Holding董事会和首席执行官薪酬和经验的分析,以及公司内部人士是否一直在购买股票。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发